Top Tweets for #flagshipfounded
Today we announced an investment from @gatesfoundation to discover new medicines for preeclampsia/eclampsia. Using our ProFoundry™ Platform & AI, we will explore the expanded proteome to understand the biology affecting mothers & babies at risk. Details: https://t.co/3sp8VjbM7o

New Phase 3 results from Flagship-founded @moderna_tx and @Merck represent an important milestone in their work on this individualized mRNA-based cancer therapy — and a meaningful step for mRNA medicine. #FlagshipFounded #BiggerLeaps
Moderna and @Merck today announced positive topline results from the Phase 3 INTerpath-001 trial evaluating adjuvant treatment with intismeran autogene, a novel investigational mRNA-based individualized neoantigen therapy jointly developed by Merck and Moderna, in combination with KEYTRUDA® (pembrolizumab), Merck's anti-PD-1 therapy, in patients with completely resected Stage IIB-IV melanoma.
Read more:

Today we announced that the U.S. Food and Drug Administration has approved mFLUSIVA® (mRNA-1010), a new vaccine against seasonal influenza, for use in all adults 50 years and older.
This approval follows unanimous recommendations from the FDA's Vaccines and Related Biological Products Advisory Committee supporting mFLUSIVA for adults 50 years of age and older.
Read more: https://t.co/gZBWPDwnr9

.#FlagshipFounded @SailBiomeds announced today a collaboration and option agreement with @JNJInnovation to advance it’s In Vivo CAR-T platform for immune-mediated diseases.
This milestone reflects years of pioneering work across the Flagship ecosystem—from foundational innovations in eRNA and targeted nanoparticle delivery to the creation of a platform with the potential to unlock an entirely new generation of programmable medicines.
Read the full announcement: https://t.co/zuTndYqzB3

Join us in welcoming Joe Romanelli as CEO-Partner and President and CEO of #FlagshipFounded @TesseraTx.
More: https://t.co/6LuCx3YtKo

As part of Boston’s first @Techweek_ , Flagship hosted a series of conversations and events bringing together founders, builders, investors, and industry leaders shaping what’s next.
We kicked things off with @enginexyz and @Pillar_VC, featuring pitches from #FlagshipFounded companies @LilaSciences and @generate_biomed on autonomous scientific discovery and generative biology.
#FlagshipFounded @Extuitive_Inc also hosted a discussion on how businesses can use AI to accelerate growth and stay competitive.
We wrapped the week with an all-day hackathon from @Flagship_PI, where teams built AI agents designed to hypothesize, experiment, and iterate with minimal human intervention.
If Boston Tech Week was any indication, the future of discovery will be built at the intersection of AI, science, and entrepreneurship. #BostonTechWeek

#FlagshipFounded @moderna_tx is #1 on @TIME's list of the World’s Most Impactful Companies of 2026. Moderna has helped redefine what’s possible for medicine: translating a pioneering mRNA platform into products that have impacted millions of lives globally. #BiggerLeaps

Our latest 3 Questions video is out now, featuring Flagship Origination Partner and CEO of #FlagshipFounded Serif Biomedicines, Jake Rubens.
Hear his perspective on pursuing bold science, rethinking the “alphabet” of life, and the power of curiosity. Watch the full video to learn more.
Today #FlagshipFounded @HarbingerHlth announced RESOLVE™, a new category of blood-based multi-cancer detection tests designed to reduce uncertainty in cancer detection — alongside $100M in financing to advance its development.
Today Harbinger Health announced RESOLVE™, a new category of blood-based multi-cancer detection tests aimed at providing guidance during the critical period between suspicion of cancer — symptoms, signs or findings — and diagnosis. Learn more. https://t.co/HGoLVcN0kJ

The recent announcement of #FlagshipFounded @QuotientTx's collaboration with @Merck underscores the growing impact of somatic genomics in biomedicine.
Somatic genomics is a new frontier in genetics that focuses not on the single inherited genome, but on the trillions of evolving genomes that exist across the cells in our bodies. These somatic mutations arise throughout life, creating a natural genetic experiment within human tissue.
By leveraging these insights, Quotient’s platform systematically translates natural somatic genetic variation into disease-causal targets to develop first-in-class therapies.
Learn more about Quotient Therapeutics: https://t.co/IabeLsEHJO
#FlagshipFounded @QuotientTx’s somatic genomics platform reveals disease biology by analyzing trillions of mutations. Paired with @Merck's global development capabilities, this collaboration aims to turn these insights into transformative therapies for patients.
We’re thrilled to announce our collaboration with @Merck to discover novel drug targets in IBD using our #SomaticGenomics platform. Together, we aim to uncover unique biological insights that drive the discovery of more effective tx for patients. Read more:https://t.co/dfpCMCNfef
The recent announcement that #FlagshipFounded @TesseraTx received U.S. FDA Fast Track and Orphan Drug Designations for its lead in vivo gene editing program, TSRA-196, marks an important milestone for Gene Writing™.
Pioneered by @TesseraTx, Gene Writing™ is a genome engineering approach designed to write therapeutic messages directly into the human genome. Gene Writers can precisely substitute a base pair, insert or delete short sequences, or write entire genes into DNA, all with the goal of addressing disease at its source.
By directly correcting the underlying DNA sequence, Gene Writing™ seeks to address the root cause of disease — with the potential to move beyond chronic management toward durable, potentially one-time treatment.
With growing momentum, Tessera continues advancing its Gene Writing™ programs toward clinical translation.
Learn more about Tessera: https://t.co/9XKt1Mr13G
.@generate_biomed marked a major milestone today with its IPO on the #Nasdaq.
#FlagshipFounded Generate is pioneering a new era of programmable biology to engineer better medicines for patients, faster. $GENB
At the crossroads of machine learning, automated experimentation and cutting-edge science, @generate_biomed is revolutionizing drug discovery and development.
Here’s to building the future of medicine, $GENB! #NasdaqListed

Stay up to date on the latest news from Flagship and our ecosystem of #FlagshipFounded companies. Discover insights from our leaders and explore the ideas, breakthroughs, and bold science driving our work. Subscribe to Flagship Futures: https://t.co/J4euGv2Qk0
In this installment of ⏰ Off the Clock ⏰, Flagship Origination Partner Scott Lipnick shares what he enjoys most about working at Flagship, how his team would describe him, and his work to advance Preemptive Health and Medicine. See that work in action at #FlagshipFounded @etiome , where Scott serves as President.
Watch to learn more about Scott and his hobbies outside of the office. #WeAreFlagship
Interested in joining the Flagship team? View our open roles: https://t.co/0IRXCapO5r
Learn more about our Preemptive Health and Medicine work here: https://t.co/Gq7o1VR71J
Meet Jack Kirsch, Senior Associate, in our ⏰ Off the Clock ⏰ series. Learn about his experience helping launch #FlagshipFounded Expedition Medicines; his woodworking goals; and where you can find him off the clock. 🚴♂️ #WeAreFlagship
👋 Meet more members of our team and stay tuned for more spotlights on Flagship pioneers: https://t.co/m5nL0Sx9x5
💼 Interested in joining the Flagship team? View our open roles: https://t.co/0IRXCapO5r
Hear from the CEOs and leaders of #FlagshipFounded companies who are advancing novel science and breakthroughs redefining what's possible for human health. Watch all the conversations from the #FlagshipStudio on our #JPM26 page now: https://t.co/xrKSovdPjx
Today, #FlagshipFounded @RepertoireIM announced a collaboration with @EliLillyandCo to discover new T cell-targeted medicines for autoimmune disease by leveraging Repertoire’s DECODE™ platform. Together, the two companies aim to create medicines that reset the immune system and provide durable remission for patients.
Hear directly from Repertoire CEO Torben Straight Nissen on the collaboration below.
Learn more about the partnership: https://t.co/J40Zk7quom
This week, leaders of #FlagshipFounded companies shared how they’re building differentiated platforms and advancing next-generation medicines. Watch their CEO Chats from the #FlagshipStudio during #JPM26: https://t.co/NpTG6EHuhk
🔹 Craig Williams, @AprioriBio
🔹 Ad Rawcliffe, @etiome
🔹 Ajit Singh, @HarbingerHlth
🔹 Angela Hwang, @MetaphoreBio

Imagine if we could remove more than 600,000 passenger vehicles from the road for one year. That’s the projected impact of #FlagshipFounded @Indigoag Ag’s landmark agreement with @Microsoft — proof that credible, scalable climate solutions emerge from early, sustained investment in systems, science, and platforms.
Indigo has just closed one of the largest agricultural soil carbon removal deals to date with @Microsoft.
A major milestone for the voluntary carbon market, Microsoft has agreed to purchase 2.85 million credits through Carbon by Indigo.
👉 https://t.co/F4S0ezdM4P
@msPartner

Last Seen Hashtags on Sotwe
smno filter:videos
MGAI((()))+filter:native_video
Seen from Canada
رقص_عربي_ساخن
colegialas((((((((((((((((((()))))))))))))))))))********** filter:videos
Seen from United States
brosis
Seen from Brazil
renafukiishi
Seen from Turkey
TasseAGoGo
Seen from United States
BeardedKiss
Seen from Brazil
ダイブロ
Seen from Vietnam
snapchat
Seen from United States
Most Popular Users

Elon Musk 
@elonmusk
241.7M followers

Barack Obama 
@barackobama
119M followers

Cristiano Ronaldo 
@cristiano
114.4M followers

Donald J. Trump 
@realdonaldtrump
111.9M followers

Narendra Modi 
@narendramodi
107.2M followers

Rihanna 
@rihanna
98.7M followers

NASA 
@nasa
92.4M followers

Justin Bieber 
@justinbieber
91.8M followers

KATY PERRY 
@katyperry
90M followers

Taylor Swift 
@taylorswift13
83.9M followers

Lady Gaga 
@ladygaga
75.4M followers

Virat Kohli 
@imvkohli
73.3M followers

Kim Kardashian 
@kimkardashian
70.9M followers

YouTube 
@youtube
68.8M followers

Neymar Jr 
@neymarjr
66.3M followers

Bill Gates 
@billgates
65.1M followers

Selena Gomez 
@selenagomez
63M followers

The Ellen Show
@theellenshow
62.3M followers

CNN 
@cnn
61.8M followers

X 
@x
60.7M followers















